abiraterone,olaparib
astrazeneca,merck
['olaparib']
 do you think adding olaparib is justified in the hrrneg patients based on this data? taking into account the potential small benefit at the cost of increased toxicity by adding the drug.
Postdoc @UrologicalRunit. 
Interested in Urology and #ProstateCancer Epidemiology & Personalized medicine for bettering the patient's life.
Opinions are my own.